← Back to Search

Prehabilitation in Esophageal Cancer Care

N/A
Waitlist Available
Led By Enrico M Minnella, MD PhD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Patients with non-metastatic esophageal cancer undergoing neo-adjuvant chemotherapy and surgery.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if prehabilitation, which is preparing for surgery beforehand, can help people with esophageal cancer.

Eligible Conditions
  • Esophageal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Oxygen consumption (VO2)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Supervised PrehabilitationExperimental Treatment1 Intervention
Prehabilitation will include exercise, nutrition, and anxiety-coping intervention. This group will receive a supervised, in-hospital training.
Group II: Home-based PrehabilitationExperimental Treatment1 Intervention
Prehabilitation will include exercise, nutrition, and anxiety-coping intervention. This group will receive a home-based training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prehabilitation
2013
Completed Phase 3
~1040

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
471 Previous Clinical Trials
166,903 Total Patients Enrolled
Enrico M Minnella, MD PhDPrincipal InvestigatorMcGill University
~9 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top